These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10393683)

  • 1. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
    Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
    Singer JS; Mhoyan A; Fishbein MC; Shen XD; Gao F; Zhao D; Coito AJ; Reemtsen BL; Amersi F; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2001 Oct; 72(8):1408-16. PubMed ID: 11685113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
    Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
    Semiletova NV; Shen XD; Baibakov B; Andakyan A
    J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506.
    Gibson SW; Valente JF; Alexander JW; Custer DA; Li BG; Frede S; Babcock GF; Ogle CK
    Transplantation; 2000 May; 69(10):2034-8. PubMed ID: 10852592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplantation; 1995 Oct; 60(7):729-33. PubMed ID: 7570985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
    Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
    J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
    Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW
    Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
    J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
    Levy AE; Alexander JW; Babcock GF
    Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection.
    Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV
    J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.